Valuation: aXichem AB

Market Cap 129M 12.81M 11.39M 10.62M 9.68M 18.27M 1.23B 18.43M 49.89M 629M 48.11M 47.06M 2.04B P/E 2024
-2.93x
P/E 2025 -6.9x
Enterprise Value 130M 12.98M 11.53M 10.75M 9.8M 18.5M 1.25B 18.67M 50.53M 637M 48.72M 47.67M 2.06B EV / Sales 2024
7.67x
EV / Sales 2025 6.72x
Free-Float
82.56%
Yield 2024 *
-
Yield 2025 -
1 day-5.00%
1 week-11.63%
Current month-11.63%
1 month-10.38%
3 months+9.20%
6 months+29.69%
Current year-8.21%
1 week 1.86
Extreme 1.86
2.25
1 month 1.7
Extreme 1.7
2.31
Current year 1.14
Extreme 1.135
4
1 year 1.14
Extreme 1.135
4
3 years 0.9
Extreme 0.898
15.5
5 years 0.9
Extreme 0.898
30.8
10 years 0.9
Extreme 0.898
95.8
Manager TitleAgeSince
Chief Executive Officer 69 31/12/2015
Chief Operating Officer 51 15/04/2025
Investor Relations Contact 64 31/12/2014
Director TitleAgeSince
Chairman 69 05/07/2007
Chairman 80 31/12/2016
Director/Board Member 77 31/12/2016
Date Insider Type Main position Quantity % Market Cap. Importance
28/03/24 Exercice

Director

33,602 0.1563%
28/03/24 Exercice

Director

134,408 0.6253%
27/03/24 Buy

Founder

200,000 0.9304%
Change 5-day change 1-year change 3-year change Capi.($)
-5.00%-11.63%-39.87%-78.84% 13.48M
+0.90%-0.61%+1.48%+61.57% 76.04B
+0.60%-1.35%+4.51%+12.22% 37.12B
+2.60%+0.93%+3.17%-21.15% 34.6B
+0.53%-2.46%+4.78%+7.17% 31.15B
+0.73%-6.07%+5.24%+46.12% 28.97B
-2.33%-1.63%-8.50%+14.83% 25.76B
+1.46%+1.28%+47.30%+33.71% 23.12B
+0.62%-3.87%+48.29%+8.13% 18.32B
+0.60%-0.18%-44.61%-41.91% 17.45B
Average +0.07%-2.81%+2.18%+4.18% 29.25B
Weighted average by Cap. +0.73%-2.19%+5.71%+22.36%

Financials

2024 2025
Net sales 8.57M 853K 758K 707K 645K 1.22M 82.18M 1.23M 3.32M 41.91M 3.2M 3.13M 136M 18.45M 1.84M 1.63M 1.52M 1.39M 2.62M 177M 2.64M 7.15M 90.21M 6.9M 6.75M 292M
Net income -17.81M -1.77M -1.58M -1.47M -1.34M -2.53M -171M -2.55M -6.91M -87.11M -6.66M -6.51M -282M -17.63M -1.76M -1.56M -1.46M -1.33M -2.5M -169M -2.53M -6.84M -86.23M -6.59M -6.45M -279M
Net Debt -14.36M -1.43M -1.27M -1.18M -1.08M -2.04M -138M -2.06M -5.57M -70.22M -5.37M -5.25M -227M 1.64M 164K 145K 136K 124K 233K 15.76M 236K 637K 8.04M 615K 601K 26.05M
Logo aXichem AB
aXichem AB (publ) is a Sweden-based biochemical company. It develops an eco-friendly solution, Phenylcapsaicin. Phenylcapsaicin is an non-toxic antifouling agent, which can be used in the shipping industry, as it keeps vessels free from fouling. Additionally, the Company holds several world patents for alternative uses and applications of phenylcapsaicin. Phenylcapsaicin can be applied as bio-repellent against all living organisms in settings where animals cause damage to human installations. As of December 31, 2011, the Company had such subsidiaries, as aXichem AB, aXimed AS, aXimed KH Limited and Guizhou aXimed Health Food Co Ltd. As of June 29, 2012, the Compant’s two largest shareholders were Aximed AB (52.47%) and LMK Ventures AB (12.54%).
Employees
7
Date Price Change Volume
02/10/26 SEK 1.900 -5.00% 101,319
01/10/26 SEK 2.000 -6.98% 139,849
30/09/26 SEK 2.150 +0.47% 25,039
29/09/26 SEK 2.140 -1.83% 52,074
28/09/26 SEK 2.180 +3.81% 3,470
  1. Stock Market
  2. Stocks
  3. AXIC A Stock